Price T Rowe Associates Inc Acelrx Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.49 - $1.02 $29,596 - $61,608	-60,400 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.93 - $1.51 $32,829 - $53,303	-35,300 Reduced 36.89%	60,400 $62,000
Q2 2021 Aug 16, 2021	SELL	$1.03 - $1.7 $6,205 - $10,242	-6,025 Reduced 5.92%	95,700 $132,000
Q1 2021 May 17, 2021	BUY	$1.25 - $2.77 $127,156 - $281,778	101,725 New	101,725 $173,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.